GRAIL, Inc. Operating Income
GRAIL, Inc. (GRAL) reported Operating Income of -$173.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- GRAIL, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$173.78M.
- GRAIL, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$135.76M.
- GRAIL, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$124.41M.
- GRAIL, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$125.29M.
- GRAIL, Inc. operating income (loss) for fiscal 2025 was -$562.16M.
- GRAIL, Inc. operating income (loss) for fiscal 2024 was -$2.19B.
- GRAIL, Inc. operating income (loss) for fiscal 2023 was -$1.52B.
- GRAIL, Inc. operating income (loss) for fiscal 2023 was -$5.44B.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$173.78M 10-Q · filed 2026-08-06 | -$309.55M 10-Q · filed 2026-08-06 | -$433.96M derived: sum of 3 quarters · filed 2026-08-06 | -$559.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$135.76M 10-Q · filed 2026-05-07 | -$260.18M derived: sum of 2 quarters · filed 2026-05-07 | -$385.47M derived: sum of 3 quarters · filed 2026-05-07 | -$544.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$124.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$249.70M derived: sum of 2 quarters · filed 2026-03-12 | -$408.56M derived: sum of 3 quarters · filed 2026-08-06 | -$562.16M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$125.29M 10-Q · filed 2025-11-13 | -$284.14M derived: sum of 2 quarters · filed 2026-08-06 | -$437.75M 10-Q · filed 2025-11-13 | -$574.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$158.85M 10-Q · filed 2026-08-06 | -$312.46M 10-Q · filed 2026-08-06 | -$449.40M derived: sum of 3 quarters · filed 2026-08-06 | -$632.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$153.61M 10-Q · filed 2026-05-07 | -$290.55M derived: sum of 2 quarters · filed 2026-05-07 | -$474.05M derived: sum of 3 quarters · filed 2026-05-07 | -$2.12B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$136.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$320.44M derived: sum of 2 quarters · filed 2026-03-12 | -$1.96B derived: sum of 3 quarters · filed 2026-03-12 | -$2.19B 10-K · filed 2026-03-12 |
| 2024-09-30 | -$183.51M 10-Q · filed 2025-11-13 | -$1.82B derived: sum of 2 quarters · filed 2025-11-13 | -$2.05B 10-Q · filed 2025-11-13 | -$2.25B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$1.64B 10-Q · filed 2025-08-13 | -$1.87B 10-Q · filed 2025-08-13 | -$2.06B derived: sum of 3 quarters · filed 2026-03-12 | -$2.98B derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$227.42M 10-Q · filed 2025-05-14 | -$422.01M derived: sum of 2 quarters · filed 2026-03-12 | -$1.33B derived: sum of 3 quarters · filed 2026-03-12 | -$1.54B derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -$194.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.11B derived: sum of 2 quarters · filed 2026-03-12 | -$1.31B derived: sum of 3 quarters · filed 2026-03-12 | -$1.52B 10-K · filed 2025-03-05 |
| 2023-10-01 | -$912.39M 10-Q · filed 2024-11-13 | -$1.12B derived: sum of 2 quarters · filed 2024-11-13 | -$1.32B 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$204.37M 10-Q · filed 2024-08-13 | -$408.40M 10-Q · filed 2024-08-13 | ||
| 2023-01-01 | -$5.44B 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |